Skip to main content

Peer Review reports

From: TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

Original Submission
29 Jan 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Jan 2014 Author responded Author comments - Charlotte Jørgensen
Resubmission - Version 3
29 Jan 2014 Submitted Manuscript version 3
21 Feb 2014 Reviewed Reviewer Report - Francisco Vizoso
8 Mar 2014 Reviewed Reviewer Report - Nadia Harbeck
9 Apr 2014 Author responded Author comments - Charlotte Jørgensen
Resubmission - Version 4
9 Apr 2014 Submitted Manuscript version 4
4 May 2014 Author responded Author comments - Charlotte Jørgensen
Resubmission - Version 5
4 May 2014 Submitted Manuscript version 5
Publishing
16 May 2014 Editorially accepted
22 May 2014 Article published 10.1186/1471-2407-14-360

You can find further information about peer review here.

Back to article page